Log off SitemapDisclaimer

The transdermal fentanyl patch Matrifen® eases your pain

The transdermal pain relief patch Matrifen® from Nycomed provides pain relief for patients with severe chronic pain.

Transdermal pain relief patch - Matrifen® by NycomedThe transdermal pain patch Matrifen® is a fentanyl patch, which provides relief for patients with severe chronic pain.

>> Information on the transdermal patch Matrifen®

Matrifen® is a transdermal fentanyl patch with membrane controlled release. It is a 72 hour or 3 day patch with a skin friendly silicone adhesion layer, that sticks well to the surface of the skin.

The efficient and advanced fentanyl patch technology provides pain relief for cancer related as well as non cancer related pains and the lower drug load adds to a higher degree of safety and lower environmental burden.

About Nycomed
Nycomed is a young company with a long history. Founded in 1874 in Norway by Morten Nyegaard, the company gradually began to expand into Europe, forming a strong position initially in the Nordic countries.

The modern story really begins in 1999, when Nycomed was established as a European company with a focus on sourcing and developing new pharmaceutical products. With this in place, the pace of this market expansion increased and the company now operates throughout Europe.

Special features

To access the site you must confirm being a healthcare professional - use the link on the left side of this page

Mode of action video

An animation presenting the Matrifen® patch;
- Application
- Mode of action

Additional material

- Product details
- Pharmacokinetics
- Technical profile
Conversion tables for download 

- Oral morphine to Matrifen (100:1)
- Oral morphine to Matrifen (150:1)
- Potency table